Published in Br J Clin Pharmacol on November 01, 1988
Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax (1994) 1.38
Dose-response study with high-dose inhaled salmeterol in healthy subjects. Br J Clin Pharmacol (1992) 1.33
Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects. Br J Clin Pharmacol (1989) 1.29
Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax (1997) 1.03
Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance? Br J Clin Pharmacol (1992) 0.92
Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27. Br J Clin Pharmacol (2004) 0.82
Tolerance with beta 2-adrenoceptor agonists: time for reappraisal. Br J Clin Pharmacol (1995) 0.78
Dose response to inhaled salbutamol in chronic obstructive airways disease. Postgrad Med J (1991) 0.77
Risk/benefit ratio of long-term treatment with beta 2-adrenoceptor agonists. Lung (1990) 0.76
Regular nebulised terbutaline in chronic obstructive airways disease: dose-response studies fail to detect tolerance. Br J Clin Pharmacol (1991) 0.76
The effects of frusemide and triamterene on the hypokalaemic and electrocardiographic responses to inhaled terbutaline. Br J Clin Pharmacol (1991) 0.75
Effect of Ventolin on QTc in children with respiratory distress. J Cardiovasc Thorac Res (2016) 0.75
The role of inhaled and/or nasal corticosteroids on the bronchodilator response. Korean J Pediatr (2010) 0.75
A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest (1956) 15.11
A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest (1956) 14.82
The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther (1973) 4.56
Deposition of pressurised aerosols in the human respiratory tract. Thorax (1981) 3.73
Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci (1967) 2.97
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax (1982) 1.77
Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics. Am Rev Respir Dis (1977) 1.58
Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels. Thorax (1981) 1.46
Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline. Br J Clin Pharmacol (1983) 1.44
Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med (1980) 1.36
The lymphocyte beta-adrenoceptor in normal subjects and patients with bronchial asthma: the effect of different forms of treatment on receptor function. J Clin Invest (1976) 1.25
Lack of bronchial beta adrenoceptor resistance in asthmatics during long-term treatment with terbutaline. J Allergy Clin Immunol (1977) 1.24
Assessment of optimum dose of inhaled terbutaline in patients with chronic asthma: the use of simple, cumulative dose-response curves. Br J Dis Chest (1982) 1.18
Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation. J Allergy Clin Immunol (1977) 1.16
Evaluation of skeletal muscle tremor due to bronchodilator agents. Scand J Respir Dis (1975) 1.11
Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol. Influence of mouth rinsing and gargling. Chest (1987) 1.09
The development of drug tolerance to beta2 adrenergic agents. Chest (1978) 1.06
An assessment of physiological finger tremor as an indicator of beta-adrenoceptor function. Br J Clin Pharmacol (1983) 1.05
Reflex vagal withdrawal and the hemodynamic response to intravenous isoproterenol in the presence of beta-antagonists. Clin Pharmacol Ther (1986) 0.96
Subsensitivity to the bronchodilator action of albuterol produced by chronic administration. Am Rev Respir Dis (1977) 0.90
Extrapulmonary effects of terbutaline during prolonged administration. Clin Pharmacol Ther (1982) 0.90
Dose-response effects of albuterol aerosol compared with isoproterenol and placebo aerosols: response to albuterol, isoproterenol, and placebo aerosols. J Allergy Clin Immunol (1977) 0.87
Comparative effects of ephedrine on adrenergic responsiveness in normal and asthmatic subjects. J Allergy Clin Immunol (1978) 0.83
The lack of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol. Ann Allergy (1981) 0.81
Cardiovascular toxicity: clinical evaluation of albuterol, isoproterenol and placebo in rising dose tolerance trial. Ann Allergy (1981) 0.80
Pulmonary function and airways resistance studies on chronic stabilized asthma: comparison of acute and long-term effects of albuterol and isoproterenol aerosols. Ann Allergy (1981) 0.79
Cutaneous wound healing. N Engl J Med (1999) 19.12
Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 12.83
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (2001) 8.89
Echocardiography in chronic heart failure in the community. Q J Med (1993) 7.64
Primary non-compliance with prescribed medication in primary care. BMJ (1993) 6.80
Questionable Value of Skin Testing as a Means of Establishing an Epidemiological Index of Tuberculous Infection. Am J Public Health Nations Health (1939) 6.37
Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol (1983) 5.73
Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes. J Immunol (1973) 4.61
Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Br J Pharmacol (1968) 4.20
Association of road-traffic accidents with benzodiazepine use. Lancet (1998) 4.01
Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest (1971) 3.58
ISOLATION OF THE ANTIANEMIA FACTOR (VITAMIN Bc) IN CRYSTALLINE FORM FROM LIVER. Science (1943) 3.40
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A (1999) 3.21
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science (1990) 3.15
The assessment of beta-adrenoceptor blocking drugs in man. Br J Clin Pharmacol (1977) 3.13
Angiogenesis in wound healing. J Investig Dermatol Symp Proc (2000) 3.12
The cardio-toxicity of isoprenaline during hypoxia. Br J Pharmacol (1969) 2.94
Controlled trial of an audit facilitator in diagnosis and treatment of childhood asthma in general practice. BMJ (1995) 2.77
Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system. J Exp Med (1975) 2.56
Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. Clin Immunol Immunopathol (1975) 2.56
Controlled trial of propranolol in thyrotoxicosis. Lancet (1969) 2.54
Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland. BMJ (1996) 2.51
Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc Natl Acad Sci U S A (1989) 2.49
The selective eosinophil chemotactic activity of histamine. J Exp Med (1975) 2.45
Iodination by human polymorphonuclear leukocytes: a re-evaluation. J Lab Clin Med (1977) 2.45
Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ (1997) 2.39
Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. J Clin Invest (1991) 2.38
Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A (2001) 2.35
Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J Immunol (1982) 2.29
Peroxidase-H2O2-halide system: Cytotoxic effect on mammalian tumor cells. Blood (1975) 2.25
Histometric study of the localisation of lymphocyte subsets and accessory cells in human Mantoux reactions. J Clin Pathol (1984) 2.25
Introducing a drug formulary to general practice--effects on practice prescribing costs. J R Coll Gen Pract (1987) 2.24
Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science (1988) 2.21
What determines levels of passive smoking in children with asthma? Thorax (1997) 2.20
Treatment of acute paracetamol poisoning. Lancet (1968) 2.18
Respiratory medicine: fighting for survival. BMJ (1992) 2.15
Wound repair in the context of extracellular matrix. Curr Opin Cell Biol (1994) 2.14
Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol (1990) 2.12
ISOLATION OF AN ANTIANEMIA FACTOR (VITAMIN Bc CONJUGATE) IN CRYSTALLINE FORM FROM YEAST. Science (1945) 2.11
Close dependence of fibroblast proliferation on collagen scaffold matrix stiffness. J Tissue Eng Regen Med (2009) 2.11
Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol (1982) 2.10
Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol (1989) 2.06
Does passive smoking increase the frequency of health service contacts in children with asthma? Thorax (2001) 2.04
Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet (1973) 2.04
Natural course of alcohol use disorders from adolescence to young adulthood. J Am Acad Child Adolesc Psychiatry (2001) 2.03
Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med (1998) 2.01
In vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol (1984) 1.99
Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun (1982) 1.99
Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut (1997) 1.98
Studies on the mechanism of antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity. J Immunol (1977) 1.98
Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med (1995) 1.95
Observations on the structure, process and clinical outcomes of asthma care in general practice. Br J Gen Pract (1996) 1.94
The clinical pharmacology of beta adrenergic blocking drugs. J R Coll Physicians Lond (1976) 1.94
A double-blind placebo-controlled trial of theophylline in general practice. Br J Clin Pract (1991) 1.93
Assembly of the neutrophil respiratory burst oxidase. Protein kinase C promotes cytoskeletal and membrane association of cytosolic oxidase components. J Biol Chem (1991) 1.92
The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 1.91
Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J Clin Invest (1980) 1.89
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol (1989) 1.88
Effect of precise mechanical loading on fibroblast populated collagen lattices: morphological changes. Cell Motil Cytoskeleton (1998) 1.88
Cutaneous tissue repair: basic biologic considerations. I. J Am Acad Dermatol (1985) 1.86
Is maintenance digoxin necessary in patients with sinus rhythm? Lancet (1979) 1.86
Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med (1994) 1.86
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Relationships between the rate of synthesis of ATP and the concentrations of reactants and products of ATP hydrolysis in maize root tips, determined by 31P nuclear magnetic resonance. Arch Biochem Biophys (1985) 1.78
Role of the myeloperoxidase-H2O2-halide system in concanavalin A-induced tumor cell killing by human neutrophils. J Immunol (1979) 1.77
Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther (1977) 1.77
Uptake and Metabolic Fate of Glucose, Arabinose, and Xylose by Zea mays Coleoptiles in Relation to Cell Wall Synthesis. Plant Physiol (1982) 1.75
Characterization of an IgA rheumatoid factor: finding properties and reactivity with the subclasses of human G globulin. Immunochemistry (1972) 1.73
Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy? Arch Surg (1973) 1.72
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol (1985) 1.72
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem (1995) 1.69
Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci (1997) 1.67
Operative management of "hockey groin syndrome": 12 years of experience in National Hockey League players. Surgery (2001) 1.67
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol (1985) 1.67
An epidemiological study of digoxin prescribing in general practice. J R Coll Gen Pract (1986) 1.66
NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonate-activatable superoxide-generating system. J Biol Chem (1987) 1.66
Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. Cardiovasc Res (1976) 1.66
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol (1985) 1.65
Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils. J Biol Chem (1981) 1.65
Preoperative evaluation of patients for liver resection. Appropriate CT imaging. Ann Surg (1993) 1.65
Propranolol and the utilization of radioiodine by the human thyroid gland. Acta Endocrinol (Copenh) (1969) 1.63
Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther (1976) 1.62
Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors. Br J Pharmacol (1985) 1.61
Infective endocarditis: a survey of cases in the South-East region of Scotland, 1969-72. Thorax (1976) 1.59
Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol Clin Exp Res (2001) 1.57
Advising parents of asthmatic children on passive smoking: randomised controlled trial. BMJ (1999) 1.57
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56
Hemolysis and iodination of erythrocyte components by a myeloperoxidase-mediated system. Blood (1975) 1.56
Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol (1987) 1.55
Nicotine fading and self-monitoring for cigarette abstinence or controlled smoking. J Appl Behav Anal (1979) 1.54
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. Thorax (1993) 1.51
beta-Adrenoceptor antagonists and respiratory function. Br J Clin Pharmacol (1978) 1.50
Responding to children's disclosure of familial abuse: what survivors tell us. Child Welfare (1999) 1.49
Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade. Br J Clin Pharmacol (1989) 1.48